Ann: RELINT: FPH: Disclosure of Director and Offi

• Release Date: 21/12/12 18:11
• Summary: RELINT: FPH: Disclosure of Director and Officer Relevant Interests
• Price Sensitive: No
• Download Document  4.12KB

					

FPH
21/12/2012 16:11
RELINT

REL: 1611 HRS Fisher & Paykel Healthcare Corporation Limited

RELINT: FPH: Disclosure of Director and Officer Relevant Interests

Name of director or officer of public issuer:  Antony John CARTER
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Director

B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities:   "(i) 89 Ordinary Shares
(ii) 1,187 Ordinary Shares"

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial
Name of registered holder of securities   "(i) Antony Carter Family Trust No
2
(ii) Loughborough Investments Limited"

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition:   14 December 2012
Consideration paid for acquisition:   "(i) NZ$226.33
(ii) NZ$2,998.67"

If the relevant interest was disposed of--
Date of disposal:   Not Applicable
Consideration paid for disposal:   Not Applicable

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place:   "(i) Purchase of 89 Ordinary Shares under the
Dividend Reinvestment Plan;
(ii) Purchase of 1,187 Ordinary Shares under the Dividend Reinvestment Plan."

E Total number of transactions this notice relates to:  Two

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   31 August 2012

Name of director or officer of public issuer:  Nigel Thomas EVANS
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Director

B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities:   414 Ordinary Shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial Ownership
Name of registered holder of securities   Nigel Thomas EVANS and Janette
Elizabeth EVANS

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition:   14 December 2012
Consideration paid for acquisition:   NZ$1,044.59

If the relevant interest was disposed of--
Date of disposal:   Not Applicable
Consideration paid for disposal:   Not Applicable

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place:   Purchase of 414 Ordinary Shares under the
Dividend Reinvestment Plan

E Total number of transactions this notice relates to:  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   11 July 2012

Name of director or officer of public issuer:  Antony George BARCLAY
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Chief Financial Officer & Company Secretary

B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities:   740 Ordinary shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial Ownership
Name of registered holder of securities   Antony George BARCLAY

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition:   14 December 2012
  NZ$1,869.86

If the relevant interest was disposed of--
Date of disposal:   N/A
Consideration received from disposal: N/A

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the issue & transfer took place:   Purchase of 740 Ordinary shares under the
Dividend Reinvestment Plan

E Total number of transactions this notice relates to:  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   18 December 2012
End CA:00231586 For:FPH    Type:RELINT     Time:2012-12-21 16:11:22